Skip to main content

Advertisement

Log in

Secondary Residual Shunt After Atrial Septal Defect Closure With an Amplatzer Occluder: Surgical Removal and Evaluation of Device Biocompatibility After 7 Years

  • Case Report
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

Interventional occluder implantation has become the preferred mode of treatment in children with clinically significant atrial septal defect (ASD). The continuous increase in the number of patients treated calls for long-term data on device integrity and biocompatibility. We report a child who underwent successful interventional ASD closure at age 5 years. Secondary residual shunt occurred after 3 years of follow-up, and surgical ASD closure became necessary at age 12 years. The Amplatzer occluder device, which was removed after 7 years in vivo, showed no signs of mechanical failure, corrosion, or clinically relevant immunological response at the device–tissue interface.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Ding ZR, Qin YW, Hu JQ et al (2009) A new pan-nitinol occluder for transcatheter closure of ventricular septal defects in a canine model. Interv Cardiol 22:191–198

    Article  Google Scholar 

  2. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer Investigators (2002) Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: Results of a multicenter nonrandomized trial. Am Coll Cardiol 39:1836–1844

    Article  Google Scholar 

  3. Kong H, Wilkinson JL, Coe JY et al (2002) Corrosive behaviour of Amplatzer devices in experimental and biological environments. Cardiol Young 12:260–265

    Article  PubMed  Google Scholar 

  4. Masura J, Gavora P, Formanek A, Hijazi ZM (1997) Transcatheter closure of secundum atrial septal defects using the new self-centering Amplatzer septal occluder: Initial human experience. Cathet Cardiovasc Diagn 42:388–393

    Article  CAS  PubMed  Google Scholar 

  5. Masura J, Gavora P, Podnar T (2005) Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 45:505–507

    Article  PubMed  Google Scholar 

  6. Omeish A, Hijazi ZM (2001) Transcatheter closure of atrial septal defects in children and adults using the Amplatzer septal occluder. Interv Cardiol 14:37–44

    Article  CAS  Google Scholar 

  7. Sharafuddin MJ, Gu X, Titus JL et al (1997) Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation 95:2162–2168

    CAS  PubMed  Google Scholar 

  8. Sigler M, Jux C (2007) Biocompatibility of septal defect closure devices. Heart 93:444–449

    Article  PubMed  Google Scholar 

  9. Sigler M, Paul T, Grabitz RG (2005) Biocompatibility screening in cardiovascular implants. Z Kardiol 94:383–391

    Article  CAS  PubMed  Google Scholar 

  10. Sigler M, Jux C, Ewert P (2006) Histopathological workup of an Amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol 27:775–776

    Article  PubMed  Google Scholar 

  11. Xiangqing K, Kejiang C, Rong Y et al (2002) Transcatheter closure of secundum atrial septal defects using Amplatzer septal occluder. Chin Med 115:126–128

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henning Neubauer.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Movie clip 1. (A and B) Transthoracic echocardiographic follow-up examination from 2005. A trans-septal flow signal was detected next to the inferior margin of the Amplatzer occluder for the first time after 3 years of follow-up as demonstrated from two different angles

Movie clip 1. (A and B) Transthoracic echocardiographic follow-up examination from 2005. A trans-septal flow signal was detected next to the inferior margin of the Amplatzer occluder for the first time after 3 years of follow-up as demonstrated from two different angles

Movie clip 2. Transthoracic echocardiographic follow-up from 2008. Progression in size of the secondary ASD was documented on follow-up examinations between 2005 and 2008. The secondary ASD reached 10 mm in diameter by 2009, with the Amplatzer occluder still in situ, and eventually required surgical closure

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhu, W., Neubauer, H. Secondary Residual Shunt After Atrial Septal Defect Closure With an Amplatzer Occluder: Surgical Removal and Evaluation of Device Biocompatibility After 7 Years. Pediatr Cardiol 31, 1107–1110 (2010). https://doi.org/10.1007/s00246-010-9757-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00246-010-9757-y

Keywords

Navigation